ARIAD Pharma (ARIA), PDL BioPharma (PDLI) Complete Iclusig-Related Royalty Transaction
Tweet Send to a Friend
ARIAD Pharma (Nasdaq: ARIA) announced that it will receive $100 million in cash – $50 million upon deal execution late ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
